{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Oral+Placebo&page=61", "query": { "intervention": "Matching Oral Placebo", "page": 61 }, "page_size": 10 }, "pagination": { "page": 61, "page_size": 10, "total_count": 3459, "total_pages": 346, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Oral+Placebo&page=62&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Oral+Placebo&page=60&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T23:36:00.232Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00749788", "title": "Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "JTT-302", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Akros Pharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 150, "start_date": "2006-12", "completion_date": "2008-02", "has_results": false, "last_update_posted_date": "2013-02-04", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 1, "location_summary": "Santa Ana, California", "locations": [ { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00749788" }, { "nct_id": "NCT03919409", "title": "First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "TS-161", "type": "DRUG" }, { "name": "TS-161 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Taisho Pharmaceutical R&D Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 70, "start_date": "2019-06-03", "completion_date": "2020-02-11", "has_results": false, "last_update_posted_date": "2020-02-28", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03919409" }, { "nct_id": "NCT00385515", "title": "Efficacy of SNX-1012 in the Treatment of Oral Mucositis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stomatitis", "Oral Mucositis" ], "interventions": [ { "name": "SNX-1012 (meclocycline sulfosalicylate)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mucosal Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 81, "start_date": "2006-06", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2009-05-07", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 9, "location_summary": "Rancho Mirage, California • Bridgeport, Connecticut • Norwich, Connecticut + 6 more", "locations": [ { "city": "Rancho Mirage", "state": "California" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Norwich", "state": "Connecticut" }, { "city": "Davie", "state": "Florida" }, { "city": "Saint Louis Park", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00385515" }, { "nct_id": "NCT00788593", "title": "A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Pancreatitis", "Exocrine Pancreatic Insufficiency" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "EUR-1008 (APT-1008) High Dose", "type": "DRUG" }, { "name": "EUR-1008 (APT-1008) Low Dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 82, "start_date": "2008-01", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2014-03-12", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 9, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Gainesville, Florida + 6 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Port Orange", "state": "Florida" }, { "city": "Hines", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00788593" }, { "nct_id": "NCT03952806", "title": "Study of BHV-3241 in Participants With Multiple System Atrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple System Atrophy" ], "interventions": [ { "name": "Verdiperstat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biohaven Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 421, "start_date": "2019-07-29", "completion_date": "2022-06-30", "has_results": true, "last_update_posted_date": "2023-09-29", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 29, "location_summary": "Phoenix, Arizona • La Jolla, California • Los Angeles, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03952806" }, { "nct_id": "NCT00859755", "title": "A Safety Study of ARRY-403 in Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "ARRY-403, glucokinase activator; oral", "type": "DRUG" }, { "name": "Placebo; oral", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Array BioPharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 41, "start_date": "2009-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-08-30", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00859755" }, { "nct_id": "NCT06285214", "title": "Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Interstitial Cystitis/Bladder Pain Syndrome" ], "interventions": [ { "name": "V117957", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Imbrium Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 47, "start_date": "2022-05-26", "completion_date": "2025-01-28", "has_results": true, "last_update_posted_date": "2026-03-09", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 24, "location_summary": "Homewood, Alabama • Tucson, Arizona • Little Rock, Arkansas + 20 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06285214" }, { "nct_id": "NCT06154447", "title": "Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "VX-828", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Tezacaftor", "type": "DRUG" }, { "name": "VX-118", "type": "DRUG" }, { "name": "Deutivacaftor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2023-12-12", "completion_date": "2026-07-10", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 12, "location_summary": "Hollywood, Florida • Orlando, Florida • Overland Park, Kansas + 9 more", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06154447" }, { "nct_id": "NCT01129258", "title": "Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Glucose Metabolism Disorders" ], "interventions": [ { "name": "PF-04991532", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 110, "start_date": "2010-06", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2011-03-09", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 4, "location_summary": "Chula Vista, California • Fountain Valley, California • Miami, Florida + 1 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129258" }, { "nct_id": "NCT04201093", "title": "Fixed-Dose Trial in Early Parkinson's Disease (PD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Tavapadon", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 529, "start_date": "2019-12-13", "completion_date": "2024-06-28", "has_results": true, "last_update_posted_date": "2025-07-28", "last_synced_at": "2026-10-18T23:36:00.232Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Fountain Valley, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04201093" } ] }